A Chinese medicine mask for inhibiting and improving seborrheic dermatitis and preparation method thereof

Abstract

The invention discloses a Chinese medicine mask for inhibiting and improving seborrheic dermatitis, characterized in that: the mask base liquid contains Chinese medicine powder, and the Chinese medicine powder is made of the following raw materials in parts by weight: 25-35 parts of ginseng, 25-35 parts of chuanxiong, 25-35 parts of atractylodes macrocephala, 7-12 parts of astragalus, 10-20 parts of bletilla striata, 7-12 parts of peach kernel and 7-12 parts of safflower. In the invention, the advantages of various medicines are complementary, and the medicines are used together, giving full play to the synergistic effect between the various medicines, so that the multiple active ingredients of the product act together, and the purpose of treating seborrheic dermatitis is achieved through multiple ways.

Description

Technical Field

[0001] The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine facial mask for inhibiting and improving seborrheic dermatitis and a preparation method thereof. Background Art

[0002] Dermatitis is a common inflammatory skin disease. The causes of dermatitis are complex and varied. It may be caused by internal factors such as chronic infection, endocrine and metabolic changes, blood circulation disorders, neuropsychiatric factors, genetic factors, etc. It may also be induced or aggravated by external factors such as food, inhalants, living environment, animal fur, various physical and chemical substances, etc. Dermatitis is currently divided into the following categories: seborrheic dermatitis, contact dermatitis, allergic dermatitis, hormone-dependent dermatitis, atopic dermatitis and neurodermatitis.

[0003] Among them, seborrheic dermatitis is a chronic inflammatory skin disease that occurs in the area of ​​sebum secretion. It mainly occurs on the head, face, chest and back. The cause of seborrheic dermatitis is unknown. It may be due to excessive sebum secretion, which changes the normal pH value of the skin and reduces the antibacterial ability, causing some non-pathogenic bacteria such as Bacillus ovale that originally existed on the skin to multiply in large numbers, causing secondary local inflammation. Bacteria can decompose free fatty acids and irritate the skin. In addition, drinking, endocrine dysfunction and physical and chemical factors may also have a certain impact on the occurrence of this disease.

[0004] Seborrheic dermatitis is prone to occur in areas where sebaceous glands are distributed more, such as the head, face, behind the ears, armpits, chest, between the shoulder blades, groin, etc. The initial rash is a red papule or plaque around the hair follicles, which merge with each other and are covered with greasy scales or yellow scabs. Due to the different locations of occurrence, the symptoms vary, such as head damage, severe cases may be accompanied by exudation and scabs, and have a bad smell, which can cause hair loss on the top of the head, which is called seborrheic alopecia. Gray scales or yellow scabs are seen behind the eyebrows, nose wings, and ears, and the base is flushed. Irregular yellow-red or light red patches are seen on the trunk, and are compounded with bran-like scales. In severe cases, they develop into erythroderma throughout the body. Sometimes due to scratching, secondary infections such as folliculitis, furunculosis, and lymphadenitis occur.

[0005] The disease is chronic and prone to relapse. The treatment principles are fat removal, anti-inflammatory, sterilization and antipruritic.

[0006] The main treatment measures currently adopted are external treatments:

[0007] (1) External lotions: lotions have antibacterial, exfoliating and anti-inflammatory effects. (2) Antifungal preparations: such as ketoconazole cream, miconazole cream, compound econazole cream, etc. (3) External calcineurin inhibitors: tacrolimus, pimecrolimus, etc. have no side effects of glucocorticoids and are more suitable for the delicate skin of the face. (4) Glucocorticoids: When inflammation is severe and itching is obvious, external glucocorticoids can be added as appropriate. Commonly used ones include 0.05% desonide cream (weak effect), 0.1% hydrocortisone butyrate (medium effect), and halometasone (strong effect).

[0008] Most of the above drugs contain hormones, which are extremely harmful to human health.

[0009] External application of Chinese medicine is an ideal method, but simple external application of Chinese medicine has the disadvantage of limited percutaneous absorption of effective substances. The reason is that human skin has its own barrier function, which only allows a small amount of small molecules of fat-soluble or water-soluble substances to pass through, and the effective ingredients that can reach the diseased area are very limited.

[0010] There are endless skin care products made from a variety of Chinese herbal medicines. However, due to factors such as the large molecular weight of Chinese herbal ingredients, the dissolution of various components is inconsistent and the absorption is not coordinated. The absorption effect of Chinese herbal skin care products is poor, the skin care effect is not obvious, and effective therapeutic effects cannot be achieved. Summary of the invention

[0011] In order to solve the above technical problems, the object of the present invention is to provide a Chinese medicine facial mask for inhibiting and improving seborrheic dermatitis and a preparation method thereof.

[0012] In order to achieve the above-mentioned purpose, the technical solution of the present invention is: a Chinese medicine facial mask for inhibiting and improving seborrheic dermatitis, characterized in that: the facial mask base liquid contains Chinese medicine powder, and the Chinese medicine powder is made of the following raw materials in parts by weight: 25-35 parts of ginseng, 25-35 parts of Chuanxiong, 25-35 parts of Atractylodes, 7-12 parts of Astragalus, 10-20 parts of Bletilla striata, 7-12 parts of peach kernel and 7-12 parts of safflower.

[0013] The method for preparing the Chinese medicine facial mask for inhibiting and improving seborrheic dermatitis is characterized in that it is prepared according to the following method:

[0014] (1) Add water to ginseng, chuanxiong, atractylodes, astragalus, bletilla striata, peach kernel and safflower, soak and wash, dry and grind into powder;

[0015] (2) adding deionized water to the Chinese medicine powder, maintaining the temperature at 50-60° C. to soak and blend the medicinal properties, and after soaking, filtering to obtain the Chinese medicine powder;

[0016] (3) placing the Chinese medicine powder into a heater and frying it at 110-130° C., stirring while frying;

[0017] (4) adding the fried Chinese medicine powder to the facial mask base liquid for blending, and ultrasonically treating in a water bath at 40° C. to 60° C. for 20 to 40 min to obtain a facial mask essence liquid;

[0018] (5) placing the mask base fabric into the mask purification solution and ultrasonically treating it for 5-15 minutes to obtain a Chinese medicine mask.

[0019] In the above scheme: in step (2), the soaking time is 2-3 hours.

[0020] In the above scheme: in step (3), the frying time is 10-20 minutes.

[0021] In the above scheme: the mask base fabric is silk or non-woven fabric.

[0022] In the above scheme: in step (4), the ultrasonic frequency is 20-35KHz, and the mass ratio of the Chinese medicine powder to the mask base liquid is 1:1-1.2.

[0023] In the above scheme: the ultrasonic frequency in step (5) is 1.40 to 1.94 KHz.

[0024] The present invention selects the above-mentioned drugs for combination, and the combination of these drugs makes the efficacy of each drug produce a synergistic effect, thereby effectively treating seborrheic dermatitis. All medicinal materials are included in the 2020 edition of the Chinese Pharmacopoeia.

[0025] The raw materials of the invention are cheap and easily available, the preparation method is simple, the cost is low, the effect is good, and the invention can be used to treat seborrheic dermatitis, which is an innovation in treating seborrheic dermatitis.

[0026] The present invention adopts a treatment method of external application of Chinese medicine facial mask, 3 times a week, and a course of treatment of 3 months. During the improvement period, the patient is advised to strictly protect against the sun, and the course of treatment can be appropriately extended for those with severe conditions.

[0027] The properties, flavors, meridians, efficacy, main indications, medical records and pharmacological effects of the seven raw materials in the traditional Chinese medicine mask of the present invention are as follows:

[0028] The ginseng of the present invention is sweet, slightly bitter and warm in nature, and enters the spleen and lung meridians. It has the effects of nourishing and strengthening the body, replenishing qi and strengthening deficiency, and nourishing the lungs and spleen. Modern medicine believes that ginseng can nourish the five internal organs, has a strong effect of resisting fatigue, and improving the body's metabolism and immune function.

[0029] Atractylodes macrocephala strengthens the spleen, replenishes Qi, expels dampness and promotes diuresis, stops sweating, and stabilizes pregnancy.

[0030] Bletilla striata has the effects of stopping bleeding, nourishing the lungs, promoting tissue regeneration and relieving pain.

[0031] Peach kernel function: It can break blood and remove blood stasis, moisten dryness and lubricate the intestines. It can treat amenorrhea, abdominal mass, blood accumulation due to febrile disease, rheumatism, malaria, traumatic injury, blood stasis, swelling and pain, and constipation due to dry blood.

[0032] Safflower can promote blood circulation and relieve menstruation, dissipate blood stasis and relieve pain. It is helpful in treating amenorrhea, dysmenorrhea, lochia retention, chest pain, abdominal pain due to blood stasis, chest and flank pain, traumatic injury, and sores and swelling.

[0033] The chuanxiong described in the present invention is the rhizome of the plant chuanxiong Ligusticum chuanxiong Hort. of the umbelliferae family, which is pungent in nature and flavor, warm, and is regulated by the liver and gallbladder meridians, and has the effects of promoting blood circulation and qi, dispelling wind and relieving pain, and is used for irregular menstruation, amenorrhea, dysmenorrhea, abdominal pain due to lumps, stabbing pain in the chest and ribs, swelling and pain due to falls, headache, rheumatic arthralgia, etc. In the Ben Jing, it is said that it is used for headache caused by stroke entering the brain, cold arthralgia, slow and urgent muscle spasm, metal wound, and blood stasis and childlessness in women. In the Ming Yi Bie Lu, it is said that it is used for removing cold movement in the brain, wind coming and going on the face, tears in the eyes, much spitting, being drunk suddenly, cold air, hard pain in the heart and abdomen, nausea, sudden swelling and pain, wind pain in the ribs, and warming the middle and internal cold. In the Yao Xing Lun, it is said that it is used for treating weakness of waist and feet, hemiplegia, preventing the placenta from coming out, and treating cold pain in the abdomen. Modern pharmacological studies have shown that chuanxiong contains ingredients such as ligustrazine, ligustilide, and new ligustilide. It has the effects of resisting myocardial ischemia, improving blood rheology, resisting cerebral ischemia, and antipyretic and sedative.

[0034] Astragalus described in the present invention is the root of leguminous plant Astragalus membranaceus (Fisch.) Bge.var.mongholicus (Bge.) Hsiao or Astragalus membranaceus (Fisch.) Bge., sweet in nature and flavor, slightly warm, belonging to the lung, spleen, liver, kidney meridians, has the effects of invigorating qi and strengthening the exterior, diuresis and strengthening the heart, lowering blood pressure and antibacterial, supporting toxins and draining pus, promoting tissue regeneration, and is used for spontaneous perspiration due to deficiency of the exterior, internal injury due to deficiency of qi, diarrhea due to deficiency of the spleen, edema and carbuncle, etc. Modern pharmacological studies have shown that Astragalus contains ingredients such as astragaloside I, II, III, IV, etc. It can enhance immunity, promote hematopoiesis, delay aging, reduce blood sugar, reduce blood pressure, reduce blood lipids, etc.

[0035] Seborrheic dermatitis is usually associated with a variety of factors in traditional Chinese medicine, such as invasion of external evils such as wind, dampness, heat, and dryness, or internal factors such as improper diet, emotional injury, and organ dysfunction. In the prescription, Atractylodes macrocephala is the main ingredient, which can replenish qi and strengthen the spleen, nourish the acquired foundation, make the qi and blood biochemical active, and is good at improving skin inflammation caused by qi and blood reversal. "Pharmacopoeia" says that it "mainly makes the face bright and happy, keeps the face young, and removes (snoring)". Modern medical research believes that there is a certain correlation between the imbalance of facial skin micro-homeostasis and the formation of skin inflammation. The number of related pathogens is found to be increased in the skin lesions of patients with skin inflammation. Studies have shown that the occurrence of skin inflammation is related to the destruction of the integrity of the skin stratum corneum and the difficulty in restoring the barrier function. The ginsenoside Rg3 in this product can effectively promote the repair of diabetic skin damage. The possible mechanism is to control the inflammatory response, increase the thickness of the epidermis and dermis, inhibit the growth stagnation period of epidermal cells, activate the proliferation period, and improve the vulnerable state of diabetic skin. The bletilla striata polysaccharide added in the product is the main active ingredient of the bletilla striata plant of the orchid family Bletilla striata. It has pharmacological activities such as promoting coagulation, anti-inflammatory and antioxidant, promoting wound healing, anti-tumor and regulating the body's immunity. It is biodegradable and has no toxic side effects. At the same time, it has the auxiliary material characteristics of suspending and thickening, film-forming adhesion, coating solubilization, targeted sustained release, enhancing efficacy and reducing toxicity, etc. It can play the role of "drug and excipient in one" and has broad application prospects in the fields of drug delivery systems and wound repair.

[0036] The advantages of the various medicines in the present invention are complementary, and the medicines are used together to give full play to the synergistic effect of the various medicines, so that the multiple active ingredients of the product work together to achieve the purpose of treating seborrheic dermatitis through multiple pathways. DETAILED DESCRIPTION

[0037] The present invention will be further described below in conjunction with the embodiments.

[0038] Example 1

[0039] Step 1: Add 25g of ginseng, 25g of Chuanxiong, 25g of Atractylodes macrocephala, 7g of Astragalus, 10g of Bletilla striata, 7g of peach kernel and 7g of safflower according to their weight ratio, add 300ml of water, soak for 15 minutes, wash, dry and grind into powder.

[0040] Add 500 ml of deionized water to the Chinese medicine powder, keep the temperature at 50-60°C and soak for 2 hours to blend the medicinal properties. After soaking, filter to obtain the Chinese medicine powder;

[0041] Put the Chinese medicine powder into a heater and stir-fry at 110°C to stimulate the medicinal properties, stirring while frying for 20 minutes.

[0042] The fried Chinese medicine powder is added into the facial mask base liquid for blending, the weight ratio of the Chinese medicine powder to the facial mask base liquid is 1:1, and the facial mask essence is obtained by ultrasonic treatment in a water bath at 40°C to 60°C for 40 minutes at an ultrasonic frequency of 20 to 35 KHz.

[0043] The mask base fabric (the mask base fabric is silk or non-woven fabric, and of course other materials can also be selected) is placed in the mask purification solution, and ultrasonically treated for 15 minutes at an ultrasonic frequency of 1.40 to 1.94 KHz to obtain a traditional Chinese medicine mask.

[0044] Example 2

[0045] Step 1: Add 29g of ginseng, 35g of Chuanxiong, 25g of Atractylodes macrocephala, 7g of Astragalus, 15g of Bletilla striata, 10g of peach kernel and 10g of safflower according to their weight ratio, add 500ml of water, soak for 20 minutes, wash, dry and grind into powder.

[0046] Add 500 ml of deionized water to the Chinese medicine powder, keep the temperature at 50-60°C and soak for 2 hours to blend the medicinal properties. After soaking, filter to obtain the Chinese medicine powder;

[0047] Put the Chinese medicine powder into a heater and stir-fry at 130°C to stimulate the medicinal properties. Stir while frying for 10 minutes.

[0048] The fried Chinese medicine powder is added into the facial mask base liquid for blending, the weight ratio of the Chinese medicine powder to the facial mask base liquid is 1:1, and the facial mask essence is obtained by ultrasonic treatment in a water bath at 40°C to 60°C for 20 minutes at an ultrasonic frequency of 20 to 35 KHz.

[0049] The mask base fabric (the mask base fabric is silk or non-woven fabric, and of course other materials can also be selected) is placed in the mask purification liquid, and ultrasonically treated for 5 minutes at an ultrasonic frequency of 1.40 to 1.94 KHz to obtain a traditional Chinese medicine mask.

[0050] Example 3

[0051] Step 1: Mix 30g of ginseng, 30g of Chuanxiong, 35g of Atractylodes macrocephala, 12g of Astragalus, 20g of Bletilla striata, 12g of peach kernel and 12g of safflower according to their weight ratio, add 500ml of water, soak for 25 minutes, wash and dry, and grind into powder.

[0052] Add 500 ml of deionized water to the Chinese medicine powder, keep the temperature at 50-60°C and soak for 2 hours to blend the medicinal properties. After soaking, filter to obtain the Chinese medicine powder;

[0053] Put the Chinese medicine powder into a heater and stir-fry at 120°C to stimulate the medicinal properties. Stir while frying for 10 minutes.

[0054] The fried Chinese medicine powder is added into the facial mask base liquid for blending, the weight ratio of the Chinese medicine powder to the facial mask base liquid is 1:1.2, and the facial mask essence is obtained by ultrasonic treatment in a water bath at 40°C to 60°C for 30 minutes at an ultrasonic frequency of 20 to 35 KHz.

[0055] The mask base fabric (the mask base fabric is silk or non-woven fabric, and of course other materials can also be selected) is placed in the mask purification liquid, and ultrasonically treated for 5-15 minutes at an ultrasonic frequency of 1.40-1.94 KHz to obtain a traditional Chinese medicine mask.

[0056] The beneficial effects of the present invention are further described below through test examples:

[0057] 1. Evaluation of efficacy in patients with seborrheic dermatitis

[0058] 1.1 Case selection

[0059] The diagnostic criteria refer to the "Guidelines for Primary Diagnosis and Treatment of Atopic Dermatitis (2022)" developed by the Pigment Disease Group of the Dermatology and Venereology Committee of the Chinese Association of Integrated Traditional Chinese and Western Medicine.

[0060] Inclusion criteria: (1) meeting the diagnostic criteria; (2) being female and aged 35 to 50 years; (3) not having any improvement within at least 4 weeks; (4) ensuring that the daily exposure to sunlight during the observation period is less than 15 minutes; (5) voluntarily joining the research project and signing the informed consent.

[0061] Exclusion criteria: (1) pregnant women, women who are planning to become pregnant, or women who are breastfeeding; (2) patients with serious primary diseases of major organ systems, endocrine system diseases, malignant tumors, mental illness, etc.; (3) patients who have used other methods to improve within 4 weeks; (4) patients who stopped improving or changed drugs or methods during the improvement period; (5) patients whose efficacy cannot be judged or whose data are incomplete and affect the judgment of efficacy; (6) other cases that do not meet the inclusion criteria; (7) patients with other skin diseases on the face; (8) patients who work outdoors for a long time or are accidentally exposed to the sun for a long time during the improvement process; (9) patients with serious adverse reactions during the improvement process.

[0062] 1.2 General Information The observed cases were 150 patients with seborrheic dermatitis who were initially diagnosed in the dermatology department of the hospital between April 2023 and April 2024. They were divided into an improvement group of 90 cases, control group 1 and control group 2 according to the random number table method, with 30 cases in each group.

[0063] The age of the patients in the improved group ranged from 33 to 46 years old, with an average age of (43.45±3.63) years; the course of disease ranged from 3 to 11 years, with an average of (4.45±1.57) years.

[0064] The age of the patients in the control group 1 ranged from 34 to 43 years old, with an average age of (41.12±2.72) years; the course of disease ranged from 3 to 10 years, with an average of (5.62±0.42) years.

[0065] The age of the control group 2 was 36 to 45 years old, with an average age of (42.17±3.53) years; the course of disease was 3 to 12 years, with an average of (5.02±0.78) years. There was no significant difference in the general data among the three groups (P>0.05), and they were comparable.

[0066] 1.3 Improvement Methods

[0067] Preparation method: The improvement group was divided into three groups, each with 30 people, and each group was soaked with the mask essence of Examples 1-3. The mask base refers to the supporting material used for the mask, and its main function is to carry and transfer the mask essence, while ensuring good fit between the mask and the skin. The material of the mask base is diverse, including cellulose-based materials, viscose fibers, cuprammonium fibers, alginate fibers, chitosan / viscose fiber blends, etc.

[0068] Improvement method: The improvement group first washed their face with warm water, applied the mask base to the inflamed skin lesions on the face, covered it for 30 minutes, and then removed the mask.

[0069] The control group 1 washed their faces with warm water.

[0070] The control group 2 first washed their faces with warm water and applied a conventional facial mask 2.

[0071] The above three groups were treated 3 times a week for a total of 3 months. During the improvement period, patients were advised to strictly protect themselves from the sun. The clinical efficacy and the condition of the affected area before and after improvement were compared among the three groups.

[0072] 1.4 Efficacy evaluation criteria refer to the "Guidelines for Primary Diagnosis and Treatment of Atopic Dermatitis (2022)" Basically cured:

[0073] The area of ​​inflammation subsided by >90% and the color basically disappeared when viewed with the naked eye; the decline index was ≥0.8.

[0074] Significantly effective: The area of ​​inflammation subsided by >60% as seen by the naked eye, the color became significantly lighter, and the decrease index was ≥0.5.

[0075] Improvement: The area of ​​inflammation subsides by >30% as seen by the naked eye, the color becomes lighter, and the decrease index is ≥0.3.

[0076] Ineffective: The inflammation area subsided by <30% as seen by naked eyes, the color change was not obvious, and the decline index was <0.3.

[0077] Total marked efficacy = (basic cure + marked effect) / total number of cases.

[0078] Statistical analysis was performed using SPSS 13.0 software. Measurement data were expressed as "χ ± s" and the t test was used; nonparametric tests were used for rank data; and χ2 tests were used for count data. P < 0.05 was considered statistically significant.

[0079] 1.5 Improvement results are shown in Table 1

[0080]

[0081] Among the three groups, the effective rate improvement group was compared with the other two groups;

[0082] Results There was a significant difference in the effective rate between the improved group and the control group 1 (χ2=6.05, P<0.05), with the effective rates being more than 80% and 40.00% respectively, indicating that the therapeutic effect of the improved group was significantly better than that of the control group 1.

[0083] There was a significant difference in the effective rate between the improvement group and the control group (χ2=6.05, P<0.05), with the effective rates being more than 80% and 56.67% respectively, indicating that the efficacy of the improvement group was significantly better than that of the control group.

[0084] 2. Evaluation of the efficacy of the facial mask of the present invention on other dermatitis patients

[0085] 2.1 Case selection

[0086] The diagnostic criteria refer to the "Guidelines for Primary Diagnosis and Treatment of Atopic Dermatitis (2022)" developed by the Pigment Disease Group of the Dermatology and Venereology Committee of the Chinese Association of Integrated Traditional Chinese and Western Medicine.

[0087] Inclusion criteria: (1) meeting the diagnostic criteria; (2) being female and aged 35 to 50 years; (3) not having any improvement within at least 4 weeks; (4) ensuring that the daily exposure to sunlight during the observation period is less than 15 minutes; (5) voluntarily joining the research project and signing the informed consent.

[0088] Exclusion criteria: (1) pregnant women, women who are planning to become pregnant, or women who are breastfeeding; (2) patients with serious primary diseases of major organ systems, endocrine system diseases, malignant tumors, mental illness, etc.; (3) patients who have used other methods to improve within 4 weeks; (4) patients who stopped improving or changed drugs or methods during the improvement period; (5) patients whose efficacy cannot be judged or whose data are incomplete and affect the judgment of efficacy; (6) other cases that do not meet the inclusion criteria; (7) patients with other skin diseases on the face; (8) patients who work outdoors for a long time or are accidentally exposed to the sun for a long time during the improvement process; (9) patients with serious adverse reactions during the improvement process.

[0089] 2.2 General information The observed cases were 30 patients with contact dermatitis, 30 patients with allergic dermatitis, 30 patients with hormone-dependent dermatitis, 30 patients with atopic dermatitis, and 30 patients with neurodermatitis who were initially diagnosed in the hospital's dermatology department between April 2023 and April 2024.

[0090] The patients were randomly given the Chinese medicine masks of Examples 1-3, washed their faces with warm water, and applied the mask base to the inflamed skin lesions on the face for 30 minutes, then removed the mask. The treatment was done 3 times a week for a total of 3 months. During the improvement period, the patients were advised to strictly protect themselves from the sun. The clinical efficacy and the condition of the affected area before and after improvement of the three groups were compared.

[0091] The improvement results were: the effective rate in the contact dermatitis group was 63.3%, the effective rate in the allergic dermatitis group was 53.3%, the effective rate in the hormone-dependent dermatitis group was 70%, and the effective rates in atopic dermatitis and neurodermatitis were 66.67% and 73.3% respectively.

[0092] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A Chinese medicine facial mask for inhibiting and improving seborrheic dermatitis, characterized in that: The facial mask base liquid contains Chinese medicinal powder, which is prepared from the following raw materials in parts by weight: 25-35 parts of ginseng, 25-35 parts of chuanxiong, 25-35 parts of atractylodes macrocephala, 7-12 parts of astragalus, 10-20 parts of bletilla striata, 7-12 parts of peach kernel and 7-12 parts of safflower.

2. The method for preparing the Chinese medicine facial mask for inhibiting and improving seborrheic dermatitis according to claim 1, characterized in that: Prepared as follows: (1) Add water to ginseng, chuanxiong, atractylodes, astragalus, bletilla striata, peach kernel and safflower, soak and wash, dry and grind into powder; (2) adding deionized water to the Chinese medicine powder, maintaining the temperature at 50-60° C. to soak and blend the medicinal properties, and after soaking, filtering to obtain the Chinese medicine powder; (3) placing the Chinese medicine powder into a heater and frying it at 110-130° C., stirring while frying; (4) adding the fried Chinese medicine powder to the facial mask base liquid for blending, and ultrasonically treating in a water bath at 40° C. to 60° C. for 20 to 40 min to obtain a facial mask essence liquid; (5) placing the mask base fabric into the mask essence and ultrasonically treating it for 5-15 min to obtain a Chinese medicine mask.

3. The method for preparing the Chinese medicine facial mask for inhibiting and improving seborrheic dermatitis according to claim 2, characterized in that: In step (2), the soaking time is 2-3 hours.

4. The method for preparing the Chinese medicine facial mask for inhibiting and improving seborrheic dermatitis according to claim 3, characterized in that: In step (3), the frying time is 10-20 minutes.

5. The method for preparing a Chinese medicine facial mask for inhibiting and improving seborrheic dermatitis according to any one of claims 2 to 4, characterized in that: The facial mask base fabric is silk or non-woven fabric.

6. The method for preparing the Chinese medicinal facial mask for inhibiting and improving seborrheic dermatitis according to claim 5, characterized in that: In step (4), the ultrasonic frequency is 20 to 35 KHz, and the mass ratio of the Chinese medicine powder to the mask base liquid is 1:1-1.

2.

7. The method for preparing the Chinese medicine facial mask for inhibiting and improving seborrheic dermatitis according to claim 6, characterized in that: The ultrasonic frequency in step (5) is 1.40 to 1.94 KHz.

Images